Table 4:
Comparison of group average value of FA and MD for the tracts of interest identified by AAFC in patients with MDD versus HC subjects.
Tracts | FA | MD | ||||
---|---|---|---|---|---|---|
MDD | HC | p-value | MDD (× 1e-3) | HC (× 1e-3) | p-value | |
ILF (L) | 0.554 ± 0.030 | 0.541 ± 0.031 | 0.051 | 0.719 ± 0.029 | 0.732 ± 0.024 | 0.043 |
ILF (R) | 0.551 ± 0.032 | 0.547 ± 0.037 | 0.634 | 0.708 ± 0.017 | 0.712 ± 0.022 | 0.253 |
CB (L) | 0.477 ± 0.025 | 0.477 ± 0.030 | 0.997 | 0.718 ± 0.025 | 0.730 ± 0.021 | 0.032 |
CB (R) | 0.466 ± 0.028 | 0.464 ± 0.028 | 0.806 | 0.712 ± 0.029 | 0.720 ± 0.020 | 0.086 |
UF (L) | 0.470 ± 0.036 | 0.471 ± 0.038 | 0.843 | 0.728 ± 0.032 | 0.726 ± 0.025 | 0.752 |
UF (R) | 0.472 ± 0.042 | 0.464 ± 0.035 | 0.326 | 0.724 ± 0.028 | 0.730 ± 0.024 | 0.263 |
CST (L) | 0.649 ± 0.027 | 0.638 ± 0.023 | 0.068 | 0.683 ± 0.022 | 0.688 ± 0.020 | 0.290 |
CST (R) | 0.641 ± 0.022 | 0.633 ± 0.022 | 0.126 | 0.675 ± 0.017 | 0.679 ± 0.017 | 0.339 |
TF (L) | 0.536 ± 0.026 | 0.529 ± 0.021 | 0.193 | 0.662 ± 0.021 | 0.668 ± 0.022 | 0.191 |
TF (R) | 0.526 ± 0.023 | 0.520 ± 0.020 | 0.192 | 0.665 ± 0.017 | 0.673 ± 0.016 | 0.035 |
TP (L) | 0.522 ± 0.035 | 0.518 ± 0.027 | 0.639 | 0.691 ± 0.024 | 0.700 ± 0.023 | 0.075 |
TP (R) | 0.523 ± 0.026 | 0.521 ± 0.024 | 0.779 | 0.695 ± 0.021 | 0.701 ± 0.019 | 0.168 |
TO (L) | 0.586 ± 0.035 | 0.578 ± 0.035 | 0.341 | 0.745 ± 0.039 | 0.746 ± 0.031 | 0.891 |
TO (R) | 0.585 ± 0.045 | 0.593 ± 0.039 | 0.385 | 0.737 ± 0.032 | 0.738 ± 0.027 | 0.868 |